Medtronic Recalls pH Monitoring Capsule Due to Risk of Serious Injuries, Including Airway Obstruction

Medtronic has initiated a recall of its Bravo CF pH monitoring capsules following reports of 184 serious injuries. The Food and Drug Administration (FDA) issued an alert regarding the device, citing risks such as esophageal perforation, airway obstruction, and blood loss. This is the second recall for subsets of these capsules in two years, with the FDA noting similar failure modes but different underlying causes for the problems.